Myositis clinical trials in Alabama
3 studies for Myositis are looking for participants at sites in Alabama.
Ublituximab in Autoantibody Positive Immune Mediated Necrotizing Myopathy
- University of Alabama at Birmingham School of Medicine: Division of Clinical Immunology & Rheumatology, Birmingham
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 17, 2026 · NCT07103746A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD5492 in Adult Participants With Systemic Lupus Erythematosus or Idiopathic Inflammatory Myopathies or Rheumatoid Arthritis.
- Research Site, Anniston
RecruitingPhase 1
Ages 18 to 70 · All sexes · Updated Sep 15, 2026 · NCT06916806AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.
- Artiva Investigational Site Tuscaloosa, Tuscaloosa
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Jul 31, 2026 · NCT06991114From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.